{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:18:51Z","timestamp":1767889131032,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Autism Dev Disord"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s10803-016-2712-x","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T07:22:26Z","timestamp":1453879346000},"page":"1887-1894","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Antipsychotic Use and Metabolic Monitoring in Individuals with Developmental Disabilities Served in a Medicaid Medical Home"],"prefix":"10.1007","volume":"46","author":[{"given":"Lisa M.","family":"Ruiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mackenzie","family":"Damron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle B.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Weedon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul S.","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda V.","family":"Bakian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah A.","family":"Bilder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,27]]},"reference":[{"issue":"1","key":"2712_CR1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/cap.2005.15.116","volume":"15","author":"MG Aman","year":"2005","unstructured":"Aman, M. G., Lam, K. L., & Van Bourgondien, M. E. (2005). Medication patterns in patients with autism: Temporal, regional, and demographic influences. Journal of Child and Adolescent Psychopharmacology, 15(1), 116\u2013126.","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"3","key":"2712_CR2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1108\/20441281111142611","volume":"5","author":"R Baburaj","year":"2011","unstructured":"Baburaj, R., & El Tahir, M. (2011). Monitoring for metabolic syndrome in people with intellectual disability on antipsychotic medication. Advances in Mental Health and Intellectual Disabilities, 5(3), 38\u201344.","journal-title":"Advances in Mental Health and Intellectual Disabilities"},{"issue":"3","key":"2712_CR3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","volume":"298","author":"S Bansal","year":"2007","unstructured":"Bansal, S., Buring, J., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007). Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. Journal of American Medical Association, 298(3), 309\u2013316.","journal-title":"Journal of American Medical Association"},{"issue":"1","key":"2712_CR4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1600-0447.2008.01203.x","volume":"118","author":"TP Barnes","year":"2008","unstructured":"Barnes, T. P. (2008). Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: A quality improvement programme. Acta Psychiatrica Scandinavica, 118(1), 26\u201333.","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"4","key":"2712_CR5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2788.2007.01018.x","volume":"52","author":"SW Bhaumik","year":"2008","unstructured":"Bhaumik, S. W. (2008). Body mass index in adults with intellectual disability: Distribution, associations and service implications: A population-based prevalence study. Journal of Intellectual Disability Research, 52(4), 287\u2013298.","journal-title":"Journal of Intellectual Disability Research"},{"issue":"12","key":"2712_CR6","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1007\/s10803-014-2170-2","volume":"44","author":"TR Buck","year":"2014","unstructured":"Buck, T. R., Viskochil, J., Farley, M., Coon, H., McMahon, W. M., Morgan, J., & Bilder, D. A. (2014). Psychiatric comorbidity and medication use in adults with autism spectrum disorder. Journal of Autism and Developmental Disorders, 44(12), 3063\u20133071.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"2712_CR7","doi-asserted-by":"crossref","unstructured":"Consensus development conference on antipsychotic drugs and obesity and diabetes. (2004). Journal of Clinical Psychiatry, 65(2), 267\u2013272. doi: 10.4088\/JCP.v65n0219","DOI":"10.4088\/JCP.v65n0219"},{"issue":"Suppl 2","key":"2712_CR8","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1542\/peds.2012-0900D","volume":"130","author":"DL Coury","year":"2012","unstructured":"Coury, D. L., Anagnostou, E., Manning-Courtney, P., Reynolds, A., Cole, L., McCoy, R., & Perrin, J. M. (2012). Use of psychotropic medication in children and adolescents with autism spectrum disorders. Pediatrics, 130(Suppl 2), S69\u2013S76.","journal-title":"Pediatrics"},{"issue":"Part 1(108)","key":"2712_CR9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/096979509799103151","volume":"55","author":"J Devapriam","year":"2009","unstructured":"Devapriam, J., Anand, A., Raju, L., & Bhaumik, S. (2009). Monitoring for metabolic syndrome in adults with intellectual disability on atypical antipsychotic drugs. British Journal of Developmental Disabilities, 55(Part 1(108)), 3\u201313.","journal-title":"British Journal of Developmental Disabilities"},{"issue":"1","key":"2712_CR100","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/archinte.163.9.1077","volume":"163","author":"LE Eberly","year":"2003","unstructured":"Eberly, L. E., Stamler, J., & Neaton, J. D. (2003). Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease. Archives of Internal Medicine, 163(1), 1077\u20131083.","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"2712_CR10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0165-1781(01)00234-7","volume":"101","author":"KR Fontaine","year":"2001","unstructured":"Fontaine, K. R., Heo, M., Harrigan, E. P., Shear, C. L., Lakshminarayanan, M., Casey, D. E., & Allison, D. B. (2001). Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate. Psychiatry Research, 101(3), 277\u2013288. doi: 10.1016\/S0165-1781(01)00234-7 .","journal-title":"Psychiatry Research"},{"issue":"4","key":"2712_CR11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1192\/bjp.bp.110.085670","volume":"199","author":"V Frighi","year":"2011","unstructured":"Frighi, V., Stephenson, M. T., Morovat, A., Jolley, I. E., Trivella, M., Dudley, C. A., & Goodwin, G. M. (2011). Safety of antipsychotics in people with intellectual disability. The British Journal of Psychiatry: The Journal of Mental Science, 199(4), 289\u2013295. doi: 10.1192\/bjp.bp.110.085670 .","journal-title":"The British Journal of Psychiatry: The Journal of Mental Science"},{"issue":"3","key":"2712_CR12","first-page":"137","volume":"9","author":"SI Ghate","year":"2012","unstructured":"Ghate, S. I. (2012). Predictors of metabolic parameter monitoring in adolescents on antipsychotics in a primary care setting. Mental Health In Family Medicine, 9(3), 137\u2013148.","journal-title":"Mental Health In Family Medicine"},{"issue":"3","key":"2712_CR13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1176\/appi.ajp.2008.08030383","volume":"166","author":"DW Haupt","year":"2009","unstructured":"Haupt, D. W., Rosenblatt, L. C., Kim, E., Baker, R. A., Whitehead, R., & Newcomer, J. W. (2009). Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents. The American Journal of Psychiatry, 166(3), 345\u2013353.","journal-title":"The American Journal of Psychiatry"},{"issue":"3","key":"2712_CR14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1331\/JAPhA.2008.07007","volume":"48","author":"C Hsu","year":"2008","unstructured":"Hsu, C., Ried, L. D., Bengtson, M. A., Garman, P. M., McConkey, J. R., & Rahnavard, F. (2008). Metabolic monitoring in veterans with schizophrenia-related disorders and treated with second-generation antipsychotics: Findings from a Veterans Affairs-based population. Journal of the American Pharmacists Association: Japha, 48(3), 393\u2013400. doi: 10.1331\/JAPhA.2008.07007 .","journal-title":"Journal of the American Pharmacists Association: Japha"},{"issue":"5","key":"2712_CR15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2850.2011.01781.x","volume":"19","author":"DA Koch","year":"2012","unstructured":"Koch, D. A., & Scott, A. J. (2012). Weight gain and lipid\u2013glucose profiles among patients taking antipsychotic medications: Comparisons for prescriptions administered using algorithms versus usual care. Journal of Psychiatric and Mental Health Nursing, 19(5), 389\u2013394. doi: 10.1111\/j.1365-2850.2011.01781.x .","journal-title":"Journal of Psychiatric and Mental Health Nursing"},{"issue":"1","key":"2712_CR16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1017\/S003329171100105X","volume":"42","author":"AJ Mitchell","year":"2012","unstructured":"Mitchell, A. J., Delaffon, V., Vancampfort, D., Correll, C. U., & De Hert, M. (2012). Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: Systematic review and meta-analysis of screening practices. Psychological Medicine, 42(1), 125\u2013147. doi: 10.1017\/S003329171100105X .","journal-title":"Psychological Medicine"},{"issue":"1\u20133","key":"2712_CR17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.schres.2010.11.015","volume":"126","author":"KE Moeller","year":"2011","unstructured":"Moeller, K. E., Rigler, S. K., Mayorga, A., Nazir, N., & Shireman, T. I. (2011). Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insurance. Schizophrenia Research, 126(1\u20133), 117\u2013123. doi: 10.1016\/j.schres.2010.11.015 .","journal-title":"Schizophrenia Research"},{"issue":"10","key":"2712_CR18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1192\/pb.27.10.378","volume":"27","author":"CN Morgan","year":"2003","unstructured":"Morgan, C. N., Roy, M., & Chance, P. (2003). Psychiatric comorbidity and medication use in autism: A community survey. Psychiatric Bulletin, 27(10), 378\u2013381. doi: 10.1192\/pb.27.10.378 .","journal-title":"Psychiatric Bulletin"},{"issue":"4","key":"2712_CR19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archpediatrics.2010.48","volume":"164","author":"E Morrato","year":"2010","unstructured":"Morrato, E., Nicol, G., Maahs, D., Druss, B., Hartung, D., Valuck, R., & Newcomer, J. (2010). Metabolic screening in children receiving antipsychotic drug treatment. Archives of Pediatrics and Adolescent Medicine, 164(4), 344\u2013351. doi: 10.1001\/archpediatrics.2010.48 .","journal-title":"Archives of Pediatrics and Adolescent Medicine"},{"key":"2712_CR20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0140-6736(89)91392-5","volume":"1","author":"S Mukherjee","year":"1989","unstructured":"Mukherjee, S., Schnur, D. B., & Reddy, F. (1989). Family history of type 2 diabetes in schizophrenia patients. Lancet, 1, 495.","journal-title":"Lancet"},{"issue":"3","key":"2712_CR21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","volume":"298","author":"BG Nordestgaard","year":"2007","unstructured":"Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybj\u00e6rg-Hansen, A. (2007). Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. Journal Of American Medical Association, 298(3), 299\u2013308.","journal-title":"Journal Of American Medical Association"},{"issue":"7","key":"2712_CR22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2788.2011.01421.x","volume":"55","author":"CT Paton","year":"2011","unstructured":"Paton, C. T. (2011). Nature and quality of antipsychotic prescribing practice in UK psychiatry of intellectual disability services. Journal of Intellectual Disability Research, 55(7), 665\u2013674.","journal-title":"Journal of Intellectual Disability Research"},{"issue":"2","key":"2712_CR23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","volume":"160","author":"MC Ryan","year":"2003","unstructured":"Ryan, M. C., Collins, P., & Thakore, M. B. (2003). Impaired fasting glucose tolerance in first-episode, drug-na\u00efve patients with schizophrenia. American Journal of Psychiatry, 160(2), 284\u2013289.","journal-title":"American Journal of Psychiatry"},{"key":"2712_CR24","author":"L Shi","year":"2009","unstructured":"Shi, L., Ascher-Svanum, H., Chiang, Y., Zhao, Y., Fonseca, V., & Winstead, D. (2009). Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration. BMC Psychiatry. doi: 10.1186\/1471-244X-9-80 .","journal-title":"BMC Psychiatry"},{"issue":"3","key":"2712_CR25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1744629513495261","volume":"17","author":"S Teeluckdharry","year":"2013","unstructured":"Teeluckdharry, S., Sharma, S., O\u2019Rourke, E., Tharian, P., Gondalekar, A., Nainar, F., & Roy, M. (2013). Monitoring metabolic side effects of atypical antipsychotics in people with an intellectual disability. Journal of Intellectual Disabilities, 17(3), 223\u2013235. doi: 10.1177\/1744629513495261 .","journal-title":"Journal of Intellectual Disabilities"},{"issue":"3","key":"2712_CR26","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10803-012-1617-6","volume":"43","author":"J Tsiouris","year":"2013","unstructured":"Tsiouris, J., Kim, S., Brown, W., Pettinger, J., & Cohen, I. (2013). Prevalence of psychotropic drug use in adults with intellectual disability: Positive and negative findings from a large scale study. Journal of Autism and Developmental Disorders, 43(3), 719\u2013731.","journal-title":"Journal of Autism and Developmental Disorders"},{"issue":"4","key":"2712_CR27","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1353\/hpu.2012.0175","volume":"23","author":"D Weedon","year":"2012","unstructured":"Weedon, D., Carbone, P., Bilder, D., O\u2019Brien, S., & Dorius, J. (2012). Building a person-centered medical home: Lessons from a program for people with developmental disabilities. Journal of Health Care for the Poor and Underserved, 23(4), 1600\u20131608.","journal-title":"Journal of Health Care for the Poor and Underserved"},{"issue":"3","key":"2712_CR28","first-page":"314","volume":"24","author":"A Wysoki\u0144ski","year":"2012","unstructured":"Wysoki\u0144ski, A., Kowman, M., & K\u0142oszewska, I. (2012). The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics\u2014a retrospective medical records review. Psychiatria Danubina, 24(3), 314\u2013322.","journal-title":"Psychiatria Danubina"}],"container-title":["Journal of Autism and Developmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-016-2712-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10803-016-2712-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-016-2712-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T20:54:47Z","timestamp":1559249687000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10803-016-2712-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,27]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["2712"],"URL":"https:\/\/doi.org\/10.1007\/s10803-016-2712-x","relation":{},"ISSN":["0162-3257","1573-3432"],"issn-type":[{"value":"0162-3257","type":"print"},{"value":"1573-3432","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,27]]}}}